Arrowhead Pharmaceuticals Inc (ARWR)
19.67
+0.17
(+0.87%)
USD |
NASDAQ |
Jan 07, 16:00
19.67
0.00 (0.00%)
After-Hours: 16:16
Arrowhead Pharmaceuticals Research and Development Expense (Annual): 505.87M for Sept. 30, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Sarepta Therapeutics Inc | 877.39M |
| Amgen Inc | 4.784B |
| Vertex Pharmaceuticals Inc | 3.69B |
| Avidity Biosciences Inc | 190.97M |
| Harmony Biosciences Holdings Inc | 76.06M |